Prolonged fasting currently rests on preliminary human data
Prolonged fasting means a fast longer than 24 hours, generally between 24 and 72 hours. It differs from intermittent fasting by its longer duration and its distinct metabolic impact. The practice attracts growing interest for its effects on metabolism and certain biological markers. However, applying it requires a prior assessment of individual context and comorbidities. Benefits observed in research do not apply to every profile. A cautious approach is required before considering this practice in a prevention setting.
Studies on prolonged fasting are mostly conducted in healthy people or in research settings. Data in at-risk populations are more limited. Protocol heterogeneity makes comparison of results difficult. This variability limits direct transposition to clinical practice. The health professional must therefore stay critical of generalizations.
The aim is to set out what is known and what is not yet known about prolonged fasting. The point is to help the health professional assess whether this practice is relevant for a given person. Metabolic, safety and practical aspects are covered factually and with nuance. The emphasis is on separating observational from interventional data to avoid hasty extrapolation. This clarification avoids unrealistic expectations and points toward a shared, informed decision.
The fasting mimicking diet remains the best described protocol in humans
Metabolically, prolonged fasting induces a gradual shift toward using ketone bodies as an alternative energy source. This adaptation occurs after liver and muscle glycogen reserves are depleted. It changes the energy substrate used by certain tissues, notably the brain and muscles. These metabolic changes are reversible when food intake resumes under normal conditions. They do not on their own constitute proof of a health or longevity benefit. Interpretation must stay centered on clinical outcomes demonstrated in well-controlled studies.
Some studies report effects on insulin sensitivity or on inflammatory markers. These effects are often modest and depend on context. They may be linked to overall calorie restriction rather than to fasting itself. That distinction matters for interpreting results. Comparative studies are needed to settle it.
Data on human longevity are limited and indirect, which limits definitive conclusions. Most evidence comes from animal models, with protocols that vary widely between studies. Transposition to humans carries major limits linked to physiological and metabolic differences. Effects observed in animals do not prefigure results in humans under real conditions. This difference must be explained clearly to the patient to avoid overestimating expected benefits. It tempers the extrapolations often found in non-scientific discourse.
| Strategy | Duration and frequency | Data observed in humans | Level of evidence |
|---|---|---|---|
| Fasting mimicking diet | 4 to 5 days, 3 cycles a year | Weight, insulin levels and risk factors over 3 to 6 months | Small controlled trial |
| Intermittent fasting 16:8 | Eating window of 8 to 10 hours | Modest weight loss, sleep sometimes improved | Short trials and observational data |
| Fasting over several days | 2 to 5 days, supervision required | Small studies, no demonstrated clinical benefit | Early |
| Continuous calorie reduction | 15 to 20% less, over several years | Weight, glucose, blood pressure and body composition | Established |
| 5:2 fasting | 2 days without calorie intake per week | Insulin levels and weight, short follow-up | Moderate |
Restriction strategies in humans: available data and level of evidence

The risks of a several-day fast require precise contraindications
Contraindications must be looked for systematically before considering prolonged fasting. They include pregnancy, breastfeeding, anorexia and certain confirmed eating disorders. Insulin-dependent or unstable diabetes represents a high-risk situation. Other chronic conditions can contraindicate the practice depending on how stable they are. Prior medical assessment is essential to identify any risk that is not apparent. That assessment must be adapted to each person's clinical context.
Adverse effects can occur, even in healthy and well-prepared people. They include fatigue, dizziness, headaches, irritability or digestive trouble when food intake resumes. Severity varies with the length of the fast and each person's individual sensitivity. Monitoring during the fast must be adapted to the context and the level of risk identified. Immediate stopping is required in case of persistent or worrying symptoms for the person's safety.
Preparation and the return to food are critical steps. Too rapid a return can cause significant digestive trouble. It must happen gradually with foods that are low in density and well tolerated. Hydration must be maintained throughout the period. Particular attention must be paid to electrolyte intake depending on the context.

Prolonged restriction is distinct from continuous calorie reduction
Prolonged fasting is not indicated for systematic weight loss in every profile. Effects on weight are often temporary and linked to the calorie deficit. Maintaining weight over the long term depends on other factors. The nutritional strategy must remain sustainable and adapted. For some people, other approaches are more appropriate and better tolerated.
Individualization is essential when assessing this practice. Age, physical activity, comorbidities and social context influence tolerance. A very active person will have different needs from a sedentary one. The timing chosen and professional constraints must be taken into account. This personalization limits risks and improves adherence.
The benefit to risk ratio must be assessed objectively for each person, taking their goals and context into account. Potential benefits must be weighed against the risks and the practical burden of this method. In many cases, less demanding interventions have solid evidence and better tolerance. The precautionary principle applies here in the face of persistent uncertainties. The practice should not be recommended by default, but considered only when the indication is well established.

Medical follow-up structures the fasting period and the return to food
The information given to the patient must be factual and transparent. The uncertainties that persist in the scientific literature must be stated. Expectations must be realistic about the effects to be expected. Explaining what is proven, probable or hypothetical is essential. This clarity preserves the relationship of trust. It also prevents interpretive drift.
Follow-up is recommended if prolonged fasting is considered in a specific context. It can include a clinical assessment and, where relevant, biological markers. This follow-up must be proportionate to the context and the risks identified. It makes it possible to adjust or interrupt the practice if needed.
Alternatives must always be discussed with the person being supported. Well established nutritional approaches can reach some of the targeted goals. Their tolerance is often better over the long term. The professional must present the full range of available options. This approach remains based on evidence.

Structuring the decision consultation before a first attempt
In conclusion, prolonged fasting is a practice under active research. At present, direct clinical evidence is limited for generalized use. Implementing it requires a rigorous assessment of individual risks. The indication must remain exceptional and supervised.
The distinction between experimental data and clinical application must guide any professional recommendation. This principle makes it possible to stay open to scientific advances while avoiding premature conclusions. Scientific honesty is the best answer to public interest in this practice. It protects both the health professional and the person being supported. This requirement of rigor must remain constant in the face of simplifying promises.
Ultimately, before trying a prolonged fast, the key point is to assess the benefit to risk ratio individually. Current uncertainties justify great caution in any recommendation. Supervision by a health professional is recommended in at-risk situations. This approach guarantees an informed decision centered on the person's safety.

Sources
- 1.Wei M, et al. Fasting-mimicking diet and markers/risk factors for aging, diabetes, cancer, and cardiovascular disease. Sci Transl Med. 2017.
- 2.Anton SD, et al. Flipping the metabolic switch: understanding and applying the health benefits of fasting. Obesity. 2018.
- 3.Longo VD, Mattson MP. Fasting: molecular mechanisms and clinical applications. Cell Metab. 2014.
- 4.Ezpeleta M, et al. Efficacy and safety of prolonged water fasting: a narrative review of human trials. Nutr Rev. 2024.
- 5.Shabkhizan R, et al. The beneficial and adverse effects of autophagic response to caloric restriction and fasting. Adv Nutr. 2023.
- 6.Borriello R, et al. Understanding refeeding syndrome in critically ill patients: a narrative review. Nutrients. 2025.
- 7.Liu S, et al. The health-promoting effects and the mechanism of intermittent fasting. J Diabetes Res. 2023.
Reading studies is one thing, turning them into a plan is another
The Longevity Practitioner certification teaches the method that turns this kind of data into an accompaniment decision: assess, prioritise, plan over 90 days, re-measure, and know when to hand over.
11 modules, €2,200. Enrol
Continue reading
Benjamin Sant
Co-founder of the School of Longevity
Cofounder of the School of Longevity with Tristan Maruyama. A former officer trained at Saint-Cyr from 2019 to 2022 and a coach since 2018, he has supported more than 4,000 people. He leads the School's editorial content with one constant principle: pass on only what can be situated, verified and applied seriously.
This article is published for information and education. It does not replace medical advice. For any personal health question, consult a healthcare professional.
